Acta Medica (Jan 2007)

A Pilot Study of Matrix Metalloproteinases on the Model of Daunorubicin-induced Cardiomyopathy in Rabbits

  • Anna Potáčová,
  • Michaela Adamcová,
  • Martin Štěrba,
  • Olga Popelová,
  • Tomáš Šimůnek,
  • Yvona Mazurová,
  • Ivana Gunčová,
  • Vladimír Geršl

DOI
https://doi.org/10.14712/18059694.2017.65
Journal volume & issue
Vol. 50, no. 2
pp. 109 – 111

Abstract

Read online

Matrix metalloproteinases (MMPs), activated by oxidative stress, play a key role during cardiac remodeling. In the present study we aimed to assess the role of MMPs in experimental cardiomyopathy induced by repeated 10-week administration of daunorubicin (3 mg/kg i.v.) to rabbits. In the daunorubicin group, the plasma cardiac troponin T levels (cTnT – a marker of myocardial necrosis) were significantly increased (p<0.05), commencing with the 8th administration compared with the controls. The amount of collagen (an estimate of fibrosis) was also significantly higher in the daunorubicin group (13.39 ± 0.97 mg/g wet weight) compared to the control group (10.03 ± 0.65 mg/g wet weight). In both groups, the LV MMP-activity was observed only in the gelatine substrate in the 70 kDa region (MMP-2), while no MMPs activities were detectable either in the casein or collagen containing zymograms. At the end of the experiment, the MMP- 2 activity was slightly up-regulated (by 16 %) compared with the controls.

Keywords